ILMN
Illumina, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #24
- Final score
- 71.62
- Years on list
- 7
↗ Climbed 506 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 506 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 33 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 47 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | ILMN | PFE | MRK |
|---|---|---|---|
| Climate Change | 94.8 | 82.3 | 75.3 |
| Employee Relations | 59.5 | 64.6 | 61.2 |
| Environment | 70.4 | 67.7 | 64.0 |
| Stakeholders & Society | 75.0 | 67.1 | 69.6 |
| Human Rights | 63.1 | 64.3 | 76.1 |
| Governance | 55.1 | 62.9 | 57.5 |
| Performance Rating | 62.2 | 74.4 | 73.1 |